These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1801809)

  • 1. Optimal iodine-131 dose in Graves' disease.
    Schober B; Cohen P; Lentle B
    J Nucl Med; 1991 Dec; 32(12):2359-60. PubMed ID: 1801809
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal hypothyroidism following treatment of Graves' disease: a preventable complication.
    Winternitz SR; Winternitz WW
    J Ky Med Assoc; 1976 Sep; 74(9):459-60. PubMed ID: 989494
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of influential factors correlating with early and late hypothyroidism after (131)I therapy for Graves' disease.
    Wang RF; Tan J; Zhang GZ; Meng ZW; Zheng W
    Chin Med J (Engl); 2010 Jun; 123(12):1528-32. PubMed ID: 20819506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children.
    Nebesio TD; Siddiqui AR; Pescovitz OH; Eugster EA
    J Pediatr; 2002 Jul; 141(1):99-103. PubMed ID: 12091858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 7. A simplified method for treating Graves' disease with radioactive 131I.
    Masri MT; Menne M; Rooney BL; Caplan RH
    Wis Med J; 1995 Jan; 94(1):21-5. PubMed ID: 7871797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine-induced hypothyroidism in Graves' disease: factors associated.
    Cunnien AJ; Hay ID; Gorman CA; Offord KP; Scanlon PW
    J Nucl Med; 1982 Nov; 23(11):978-83. PubMed ID: 6897075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nuclear medicine in the management of Graves' disease.
    Freitas JE
    Q J Nucl Med; 1999 Dec; 43(4):297-306. PubMed ID: 10731780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothyroidism after radioiodine therapy for Graves' disease. Is its incidence increasing?
    Gresham DG; Wool MS
    Postgrad Med; 1984 Mar; 75(4):299-305. PubMed ID: 6546620
    [No Abstract]   [Full Text] [Related]  

  • 13. Follow-up of compensated low-dose 131I therapy for Graves' disease.
    N Engl J Med; 1984 Dec; 311(25):1635-7. PubMed ID: 6548797
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term results following 131I treatment for Graves' disease in Hong Kong Chinese--discriminant factors predicting hypothyroidism.
    Kung AW; Pun KK; Lam KS; Choi P; Wang C; Yeung RT
    Q J Med; 1990 Sep; 76(281):961-7. PubMed ID: 2236479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short-term course of Graves-Basedow disease treated with I131. Prevalence of transient hypothyroidism].
    Virgili N; Gómez JM; Montaña E; Soler J; Castells M; Roca M
    Rev Clin Esp; 1988 Oct; 183(6):300-3. PubMed ID: 3217548
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of hypothyroidism after radioiodine treatment for Graves disease.
    Rosado M; Borrego LC; Paniagua ME
    Bol Asoc Med P R; 1983 Apr; 75(4):167-9. PubMed ID: 6575789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Must the high rate of hypothyroidism after radioiodine therapy for immunogenic hyperthyroidism be considered a part of the cost?].
    Emrich D
    Nuklearmedizin; 1997 Aug; 36(5):5-6. PubMed ID: 9380532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hypothyroidism caused by radioiodine therapy].
    Miclulţia M; Derevenco V; Holan T
    Stud Cercet Endocrinol; 1972; 23(4):263-9. PubMed ID: 4681800
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.